Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score.
Pérez de Llano L, Dávila I, Martínez-Moragón E, Domínguez-Ortega J, Almonacid C, Colás C, García-Rivero JL, Carmona L, García de Yébenes MJ, Cosío BG; FEOS Study Group. Pérez de Llano L, et al. J Allergy Clin Immunol Pract. 2021 Jul;9(7):2725-2731. doi: 10.1016/j.jaip.2021.01.033. Epub 2021 Feb 4. J Allergy Clin Immunol Pract. 2021. PMID: 33549843
Association Between Particulate Matter Oxidative Potential, Oxidative Stress and Inflammation, in Adult Asthmatic Patients. The ASTHMA-FENOP Study.
Santibáñez M, García-Rivero JL, Fernández-Olmo I; group of researchers of the ASTHMA-FENOP study. Santibáñez M, et al. Among authors: garcia rivero jl. Open Respir Arch. 2023 Apr 20;5(2):100246. doi: 10.1016/j.opresp.2023.100246. eCollection 2023 Apr-Jun. Open Respir Arch. 2023. PMID: 37496869 Free PMC article. No abstract available.
Cortico-dependent Asthma: Our Clinical Experience.
Pérez de Llano LA, García Rivero JL, Pallares A, Mengual N, Golpe R. Pérez de Llano LA, et al. Arch Bronconeumol. 2015 Dec;51(12):660-1. doi: 10.1016/j.arbres.2015.02.017. Epub 2015 Apr 21. Arch Bronconeumol. 2015. PMID: 25910547 English, Spanish. No abstract available.
Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.
Martínez-Rivera C, Crespo A, Pinedo-Sierra C, García-Rivero JL, Pallarés-Sanmartín A, Marina-Malanda N, Pascual-Erquicia S, Padilla A, Mayoralas-Alises S, Plaza V, López-Viña A, Picado C. Martínez-Rivera C, et al. Respir Med. 2018 Feb;135:22-28. doi: 10.1016/j.rmed.2017.12.013. Epub 2018 Jan 3. Respir Med. 2018. PMID: 29414449 Free article.
A Simple Score for Future Risk Prediction in Patients with Controlled Asthma Who Undergo a Guidelines-Based Step-Down Strategy.
Pérez de Llano L, García-Rivero JL, Urrutia I, Martínez-Moragón E, Ramos J, Cebollero P, Carballada F, Blanco-Aparicio M, Vennera MDC, Merino M, Torralba-García Y, Plaza V. Pérez de Llano L, et al. J Allergy Clin Immunol Pract. 2019 Apr;7(4):1214-1221.e3. doi: 10.1016/j.jaip.2018.10.017. Epub 2018 Oct 25. J Allergy Clin Immunol Pract. 2019. PMID: 30368006
Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study.
Pérez de Llano L, Martínez-Moragón E, Plaza Moral V, Trisan Alonso A, Sánchez CA, Callejas FJ, Vera E, Soto Campos JG, Martinez Rivera C, Alcázar Navarrete B, Urrutia Landa I, Garcia Rivero JL, Padilla Galo A, Alvarez Gutierrez F, Landete P, Ramos González J, Aracil CF, Carretero Gracia JÁ, Lluch I, Puente L, Andujar-Espinosa R, Cosío BG. Pérez de Llano L, et al. Respir Med. 2019 May;151:49-54. doi: 10.1016/j.rmed.2019.03.006. Epub 2019 Apr 1. Respir Med. 2019. PMID: 31047117 Free article. No abstract available.
Asthma, Comorbidities, and Aggravating Circumstances: The GEMA-FORUM II Task Force.
Trigueros JA, Plaza V, Domínguez-Ortega J, Serrano J, Cisneros C, Padilla A, Antón Gironés M, Mosteiro M, Martínez Moragón E, Olaguíbel Rivera JM, Delgado J, García Rivero JL, Martínez Rivera C, Garrido JJ, Quirce S; GEMAFORUM Task Force. Trigueros JA, et al. J Investig Allergol Clin Immunol. 2020 Apr 24;30(2):140-143. doi: 10.18176/jiaci.0460. Epub 2019 Oct 10. J Investig Allergol Clin Immunol. 2020. PMID: 31599723 Free article. No abstract available.
A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future.
Pérez de Llano L, Miravitlles M, Golpe R, Alvarez-Gutiérrez FJ, Cisneros C, Almonacid C, Martinez-Moragon E, Gonzalez-Barcala FJ, Ramos-Barbón D, Plaza V, Lopez-Campos JL, de-Torres JP, Casanova C, Garcia Rivero JL, Rodriguez Hermosa J, Calle Rubio M, Soler-Cataluña JJ, Cosio BG. Pérez de Llano L, et al. Int J Chron Obstruct Pulmon Dis. 2020 Sep 4;15:2091-2100. doi: 10.2147/COPD.S263430. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32943862 Free PMC article.
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
59 results